PT027 (albuterol/budesonide) is a potential first-in-class inhaled, fixed-dose combination of the short-acting beta2-agonist albuterol and budesonide, an inhaled corticosteroid. It is currently ...
Instead GPs are being told to offer a low-dose combination inhaler to be taken as needed for everyone aged 12 and above. The combination inhalers, which are now taken by unclipping the attached ...
Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs) added to long-acting β 2-agonists (LABAs) for treatment of symptomatic patients with severe and very severe COPD.